Purpose: The purpose of this study is to collect the information on patients with intracranial aneurysm (IA) receiving endovascular management in Siriraj Hospital, Mahidol University, Thailand. Materials and Methods: We retrospectively reviewed data from patients with IA who underwent endovascular treatment from January 1997 through July 2013. We collected patients' demographic data including age, sex, clinical presentations, and aneurysmal profiles, as well as endovascular treatment technique, complications, angiographic results, and regrowth rate. Treatment results included success rate, clinical findings during follow-up, and regrowth rate. Results: We reviewed data from 497 patients with 636 aneurysms (female:male ratio, 1.9:1; age range, 15-90 years; mean age, 59.18 years) and 69% presented with rupture. One hundred and twenty patients with 127 aneurysms received endovascular treatment. The most common location for endovascular treatment was the posterior communicating artery (15.8%), and endovascular techniques were used most often for posterior circulation and paraclinoid aneurysms. The success rate was approximately 99.2% with a 16.5% regrowth rate and no rebleeding. Regrowth rate did not correlate with immediate postoperative angiographic findings. We encountered 23 complications (18.1%); most commonly, intra-procedural rupture (7/23). Good outcomes occurred in approximately 95.9% of the patients.
Introduction
Intracranial aneurysm (IA) is a major cause of nontraumatic subarachnoid hemorrhage, which is associated with high mortality and morbidity. Surgical clipping was the standard treatment for aneurysms until the introduction of a detachable coil system by Guglielmi et al. in 1991 . This embolization procedure is effective with results equivalent to traditional microsurgery but is a less invasive method. [1] Endovascular coiling is now used more often for IAs, and the development of new endovascular techniques and devices is ongoing. [2, 3] According to the International Subarachnoid Aneurysm Trial, endovascular coiling was associated with a better prognosis than surgical treatment, with an absolute risk reduction of 7.4%. [4] In our institute, Siriraj Hospital, endovascular coiling to treat IAs began in 1997. The purpose of this study was to evaluate the angiographic outcomes of endovascular treatment for IAs in our hospital.
Materials and Methods

Patient characteristics
We retrospectively reviewed the medical records of 525 patients with nontraumatic IAs who had catheter angiographic studies at Siriraj Hospital between January 1997 and July 2013. We excluded patients with mycotic aneurysms and vasculitis and included 497 patients. Demographic data and clinical presentations were recorded for each patient, and the patient status was defined using the modified Rankin scale (mRS) at initial presentation and follow-up. The characteristics of all aneurysms were evaluated using digital subtraction angiography for their location, shape, size, and dome-to-neck ratio.
Endovascular procedure and technique
There were 127 aneurysms in 120 patients who had undergone endovascular treatment under general anesthesia. The characteristics and the best projection of the aneurysms were obtained from digital subtraction angiography at the time of the procedure. The goal of the treatment was to exclude the aneurysmal sac from circulation as completely as possible. Initially, a simple technique using detachable coils with a single microcatheter was planned if there was no anticipated technical difficulty or technical limitation; otherwise, additional devices or a flow diverter were considered. The procedure ended when angiographically complete occlusion was confirmed or when the last coil could not be safely introduced into the aneurysmal sac.
Data analysis was performed for the embolization technique, angiographic results, aneurysmal regrowth rate, patient outcome, and treatment complications. Angiographic results were classified as complete obliteration, subtotal obliteration (residual aneurysmal neck), and incomplete obliteration (residual aneurysmal sac or remnant) [ Figure 1 ]. [5] [6] [7] Aneurysmal regrowth was assessed at every follow-up by angiography at 3, 6, and 12 months and 2-5 years, except in the unruptured group, for whom follow-up began at 6 months. An aneurysm was considered to be regrowth if a previously treated aneurysm was found to recanalize or a residual remnant had increased in size on any follow-up angiography.
Patient outcome was assessed at the end of the procedure and during follow-up using the mRS and graded as good recovery, improvement, stable, or worse. Procedural complications were recorded and correlated with patient outcome.
Statistical analysis
The baseline characteristics of the aneurysms were compared between the group that included the entire study population and the group receiving endovascular treatment, using Fisher's exact test and Student's t-test, with P < 0.05 being considered statistically significant. Correlations between aneurysmal regrowth and therapeutic variables were evaluated by Chi-square test. Data management and all analyses were performed using PASW statistics 18.0 (SPSS Inc., Chicago, IL, USA).
Results
Of the 497 patients, there were 636 aneurysms with an average male:female ratio of 1:2 and a mean age of 59.2 years (range, 15-90 years). Most (69%) presented with subarachnoid hemorrhage. Patients' characteristics are shown in Table 1 . Of the 636 IAs, 563 (88.5%) were saccular and 73 (11.5%) were fusiform. The most common location was the posterior communicating artery (19.7%), followed by the anterior communicating artery (15.8%).
Most saccular aneurysms (73.5%) were small at <7 mm in diameter and most averaged 3-5 mm in diameter. Relatively wide-necked aneurysms (dome: neck ratio ≥1.5) were found in 47.8% of aneurysms. The angiographic characteristics of the IAs are shown in Table 2 .
Of the 636 IAs, 374 (59%) were treated surgically and 122 (19.2%) had endovascular interventions, five (0.8%) had combined surgery and endovascular treatment, and 129 (20.3%) had conservative treatment with observation only. When comparing surgical and endovascular therapy, 16.9% and 83.1% of the aneurysms occurred in the anterior circulation and 57.9% and 42.1% occurred in the posterior circulation, respectively (P = 0.000).
Of 127 aneurysms (20%) in 120 patients (24.2%) with endovascular treatment, there were 83 females (69.2%) and 37 males (30.8%), with a mean age of 59.2 years (range, 15-88 years). Ruptured aneurysms were found in 60.6% of all patients. The most commonly treated location was the posterior communicating artery (15.8%), but the proportion of endovascular treatment was higher for carotid cave aneurysms (6/18 or 33.3%) and those in the posterior circulation as follows: 45.5% (15/33) in The endovascular techniques used to treat IAs were simple coiling, device-assisted coiling, and parent artery sacrifice [ Table 5 ]. Nearly half of the aneurysms were treated with simple coiling using a single microcatheter (49%); intracranial stents were used in most cases of device-assisted coiling (25%). Flow diverter stents were used in seven aneurysms (one fusiform shape in the left cavernous internal carotid artery with the remaining in the basilar tip, basilar trunk, and intradural vertebral artery). Coronary stent graft systems (JOSTENT GRAFTMASTER with Hydrex coating system; Jomed International, Abbott Vascular, Redwood City, CA, USA) were used exclusively in three cases with fusiform aneurysms; one with vertebral artery aneurysm and another two with aneurysms in the cavernous portion of the internal carotid artery. Sacrifice of the parent artery was performed in three cases with fusiform-shaped aneurysms (two in the vertebral artery and one in the cavernous portion of the internal carotid artery). Stent-assisted coiling was the primary technique used for wide-necked aneurysms (44.2%), whereas a simple coiling technique was used in 26.9%. A comparison of the endovascular techniques used in wide-necked and small-necked aneurysms is shown in Table 6 .
Four aneurysms received combined treatment and another aneurysm repair started with clipping and was followed by a flow diverter stent. Four aneurysms received combined treatment. Treatment in one patient with a left posterior communicating aneurysm began with balloon-assisted coiling; however, after accidental intra-procedural rupture of the aneurysm occurred, we secured the aneurysm by clipping after partial coiling. In the 127 endovascular-treated IAs, we had a 99.2% success rate. One technical failure happened in a small aneurysm in the basilar artery, with a dome:neck ratio <1.5, where the tip of the microcatheter could not be positioned in the aneurysmal sac after stent deployment. Procedural complications occurred in 18.1% of cases (23 patients) and are summarized in Table 7 . One of seven patients who had intra-procedural aneurysmal sac rupture required further surgery and none had worse clinical outcomes. One patient who had coil protrusion into the parent artery required unplanned stent deployment. Four cases with stent malposition during the procedure required additional stent deployment, and 2/4 were flow diverters. Asymptomatic-delayed parent artery occlusion was found on follow-up in two cases and both were treated with covered stents. Our most serious complication occurred in one patient with a large basilar tip aneurysm. After successful embolization with an adjunctive flow diverter stent, the patient had progressive edema surrounding the coil mass with a significant mass effect to the brainstem. This patient eventually died. 5 Aneurysmal regrowth from endovascular therapy occurred in 21 aneurysms (16.5%), during a mean follow-up duration of 9.9 months. However, excluding the longest period of regrowth of 8 years, the mean duration of regrowth was 5.6 months. The predictor variables for aneurysmal regrowth are shown in Table 8 . No factors had a significant correlation with regrowth, including the initial angiographic results. However, aneurysms with a posterior circulation location, small neck (dome:neck ratio ≥1.5), small size (<7 mm), and those treated with a simple coiling technique had a greater tendency for regrowth.
After excluding 22/120 patients who were lost to follow-up, patient outcomes were evaluated in 98 patients with a mean follow-up of 7.3 months [ Table 9 ]. A good outcome was found in 67.3%, stable in 28.7%, worse in 1%, and mortality in 3%.
Regarding clinical outcomes in nine patients who presented with cranial nerve palsies, two patients had good recovery of ptosis and ophthalmoplegia at 6 and 12 months, respectively, four patients had clinical improvement within 3-6 months, two patients had no clinical change, and one patient who received adjunctive flow diverter treatment had worse diplopia.
Three deaths occurred in our series; one resulted from preexisting severe mRS because of subarachnoid hemorrhage, one was secondary to progressive edema of an embolized basilar tip aneurysm, and the other death was from unrelated causes.
Discussion
IA is a major cause of acute subarachnoid hemorrhage, resulting in catastrophic events with high morbidity and mortality of 25%-50% cases. Unruptured IA may present with headache, cranial nerve palsy, or ischemic stroke from a thromboembolic event or may be an incidental finding during brain imaging. [5] The disease is relatively common in the United States and Canada, with a prevalence of approximately 5%. [6] Several studies support endovascular therapy as a suitable technique for IA, particularly with aneurysmal hemorrhage.
In our series, IA commonly presented with subarachnoid hemorrhage (69.1%). The disease was more common in females (female:male ratio, 2:1), with a mean age of 38 years. Our patient characteristics were similar to other studies. [7] [8] [9] [10] [11] Common locations were the posterior communicating artery, anterior communicating artery, and middle cerebral artery. Our incidence differed from the previous reports in which the anterior communicating artery was the most common location. Screening brain imaging has not been a standard protocol in our clinical practice.
Although several reports suggest that larger aneurysms have a higher risk of rupture, [12] [13] [14] in our series, the primary presentation was rupture with a majority of small aneurysms <7 mm in diameter (73.5%).
In our institute, the decision for endovascular therapy involves consensus between a neurosurgeon and an interventional neuroradiologist based on cost-effectiveness; therefore, embolization was frequently indicated in locations of increased surgical difficulty, resulting in a greater proportion of coiling and in the posterior circulation and carotid cave. This finding is similar to the previous studies showing that endovascular treatment has a lower morbidity and mortality than surgical treatment in these locations. [12, 15, 16] As our standard procedure, we prefer a simple coiling technique using a single microcatheter with the goal of minimizing the intra-procedural risk while addressing cost-benefit concerns. In general, wide-necked aneurysms have limitations with this simple technique because the coils are difficult to maintain within the sac, and there is also a risk of the coil protruding into the parent artery, even after appropriate detachment. Adjunctive techniques (including balloon-assisted, stent-assisted, or double-catheter) are planned in aneurysms with unfavorable angioarchitecture for simple coiling or wide-necked aneurysms if the dome-to-neck ratio is >1.5. Brinjikji et al. suggested that if the dome-to-neck ratio was >1.6, device-assisted techniques were not required but were recommended with ratios <1.2. [15, 17] In their studies, the mean dome:neck ratio was 1.97 ± 0.59 in simple coiling aneurysm repair and 1.59 ± 0.42 in adjunctive treatment. Most often, our assisting device was an intracranial stent. Occasionally, stent deployment was unplanned but performed if coil protrusion occurred during the procedure, and we successfully used a simple coiling technique in wide-necked aneurysms (26.9%). Our mean dome:neck ratio was 1.98 ± 0.81 for the simple coiling technique (lowest ratio, 0.88) and 1.57 ± 1.21 in device-assisted procedures.
Our immediate angiographic results were 25.2% complete occlusion, 59% subtotal obliteration, and 15.7% incomplete obliteration. Our data showed no significant difference between simple coiling and device-assisted techniques. In general, larger aneurysms with wider necks typically have lower reported rates of successful occlusion [12] and reported rates of complete aneurysmal occlusion vary from 26% to 81%. [4, 8, 9, 12] The Endovascular Approach of Nonruptured Aneurysms study demonstrated complete occlusion in 43.4%-63.7% of aneurysms, neck remnant in 20.8%-23.3%, and residual aneurysmal sac in 10.9%-35.8%. [16] Wieber et al. showed that using stent-assisted coiling could totally obliterate aneurysms in 50% of cases. [17] Complications from our embolization procedure occurred in 18.1% (23) of patients. Hemorrhagic complications (5.5%) were related to intra-procedural rupture of the aneurysmal sac, and in almost all patients (6/7); management consisted of reversal of systemic heparinization and continuation of coil insertion to occlude the aneurysm as completely as possible. One patient underwent urgent aneurysm surgery for clipping. None of our hemorrhagic complications had associated mortality or worse outcome. Meta-analyses of this complication in a larger series reported an incidence of 1.4%-4.7%, with an associated mortality rate of 30%-40%. [11] Thromboembolic complications (1.2%) of the distal artery were procedure-related events and were found incidentally during controlled angiography following treatment. case where a covered stent was used in a fusiform aneurysm in the intracranial segment of the vertebral artery. [20] Saatci et al. reported a case series treating internal carotid artery aneurysms in 24 patients with a 95.8% success rate. [21] Other authors also report good results in giant aneurysms and dissecting vertebral artery aneurysms. [22, 23] In our series, we used a coronary stent graft in three cases with immediate-good angiographic results, but 2/3 had delayed asymptomatic parent artery occlusion, even with continuation of antiplatelet therapy.
The regrowth rate in our series was 16.5% and no rebleeding was found during the mean follow-up of 9.9 months. No significant predictors for aneurysmal regrowth were identified. We also found no correlation between angiographic results (complete, subtotal, and incomplete occlusion) and the rate of regrowth in our series. Reported regrowth rates vary from 0% to 42%. [1, 8, 9, 11] Raymond et al. demonstrated recanalization rates of 20% in completely occluded aneurysms versus 40.1% in those with neck remnants and 51.1% in those with aneurysmal sac remnants. [24] Li et al. reported a reopening rate of 3.5% for total occlusion, 43.5% for subtotal occlusion, and 50% for incomplete occlusion. [25] Large aneurysm size was documented to be a risk factor for reopening and retreatment, explained in part by lesser packing density and a higher proportion of aneurysms with intraluminal thrombus [ Figure 5 ]. [26] We obtained different results that may be explained by the small number of patients in our study and insufficient follow-up duration. However, because we weighed the cost-benefit ratio, we considered that it might not always be necessary to attempt complete Previous studies report a wide incidence range for this complication of 2.4%-16.7%. [7, 8] Intra-procedural device-related complications (9.4%) in our study included coil migration, coil straightening, coil protrusion, and stent malposition [ Figure 3 ], resulting in unfavorable coil packing and incomplete aneurysmal occlusion. However, no hemorrhagic or embolic events were observed.
Regarding the use of flow diverter stents, a meta-analysis by Brinjikji et al. reported 4% morbidity and 5% mortality. [18] Postoperative subarachnoid hemorrhage, intraparenchymal hemorrhage, and perforator infarction were each found in 3% of patients and ischemic stroke in 6%. The authors also showed that posterior circulation aneurysms repaired with a flow diverter stent had a greater tendency to have ischemic complications than those in the anterior circulation. We experienced only six cases with complications using this adjunctive device and almost no hemorrhagic or embolic complications. Of the three deaths in our series, one was a treatment-related death of a patient with a large nonruptured basilar tip aneurysm. He had postprocedural progressive brain edema surrounding the coil mass, with inevitable mass effect to the brainstem. This was likely result from inflammation using bioactive coil (Matrix coil; Boston Scientific Neurovascular) [ Figure 4 ]. Stent malposition occurred in two patients during the procedures, which required additional stent deployment.
Coronary stent graft for intracranial neurovascular disease was first described in 1997. [19] Chiaradio et al. reported a Our results from endovascular treatment of IA were comparable to the previous publications, with a high success rate and favorable outcome of 96%. [8] In our patients presenting with subarachnoid hemorrhage, 90.1% had good outcome; 49.2% with good recovery and 30.8% with improved clinical status, and 60% of patients with an initial mRS = 4 showed improved outcome. In our series, procedure-related mortality and morbidity were each found in one patient (0.8%), compared with reported overall morbidity and mortality rates for endovascular treatment of aneurysms of 3.7%-5.3% and 1.1%-1.5%, respectively. [4, 11] Although since 1997, endovascular technique in treatment of IA advanced overtime, according to our center's policy, we tend to treat aneurysm by simple technique. This is limitation that we did not separate result between era of stent or no stent.
Conclusions
Endovascular therapy for IA in our institute is feasible with low morbidity and mortality rates. Even a simple coiling technique was successfully used for some wide-necked aneurysms. No significant difference in aneurysmal regrowth rate was demonstrated for complete, subtotal, and incomplete occlusion. Although adjunctive techniques for wide-necked aneurysms were helpful, we consider that it is not always necessary to attempt complete aneurysmal occlusion using several devices, particularly in the rupture group when considering the cost-benefits. However, long-term angioarchitecture and clinical follow-up are required to determine the long-term safety and efficacy of endovascular treatment.
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